Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

"Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?".

Allwinn R, Bickel M, Lassmann C, Wicker S, Friedrichs I.

Med Microbiol Immunol. 2013 Apr;202(2):125-30. doi: 10.1007/s00430-012-0259-9. Epub 2012 Sep 19.

PMID:
22986732
[PubMed - indexed for MEDLINE]
2.

Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.

Loebermann M, Voss U, Meyer S, Bosse D, Fritzsche C, Klammt S, Frimmel S, Riebold D, Reisinger EC.

PLoS One. 2013 Aug 16;8(8):e70866. doi: 10.1371/journal.pone.0070866. eCollection 2013.

PMID:
23976960
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
[PubMed - indexed for MEDLINE]
Free Article
4.

Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.

McVernon J, Laurie K, Barr I, Kelso A, Skeljo M, Nolan T.

Influenza Other Respir Viruses. 2011 Jan;5(1):7-11. doi: 10.1111/j.1750-2659.2010.00172.x. Epub 2010 Aug 24.

PMID:
21138535
[PubMed - indexed for MEDLINE]
5.

Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.

Ott U, Sauerbrei A, Lange J, Schäfler A, Walther M, Wolf G, Wutzler P, Zell R, Krumbholz A.

Med Microbiol Immunol. 2012 Aug;201(3):297-302. doi: 10.1007/s00430-012-0231-8. Epub 2012 Feb 17.

PMID:
22350187
[PubMed - indexed for MEDLINE]
6.

Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.

Gorse GJ, Falsey AR, Fling JA, Poling TL, Strout CB, Tsang PH.

Vaccine. 2013 May 1;31(19):2358-65. doi: 10.1016/j.vaccine.2013.03.008. Epub 2013 Mar 13.

PMID:
23499604
[PubMed - indexed for MEDLINE]
7.

Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.

Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT.

Int J Infect Dis. 2012 Aug;16(8):e621-7. doi: 10.1016/j.ijid.2012.04.010. Epub 2012 Jun 15.

PMID:
22704721
[PubMed - indexed for MEDLINE]
Free Article
8.

Vaccination against influenza in patients with systemic sclerosis.

Litinsky I, Balbir A, Zisman D, Mandelboim M, Mendelson E, Feld J, Braun Y, Anouk M, Kaufman I, Paran D, Caspi D, Elkayam O.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S7-11. Epub 2012 May 29.

PMID:
22409886
[PubMed - indexed for MEDLINE]
9.

Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.

Zhou Y, Ng DM, Seto WH, Ip DK, Kwok HK, Ma ES, Ng S, Lau LL, Peiris JS, Cowling BJ.

PLoS One. 2011;6(11):e27169. doi: 10.1371/journal.pone.0027169. Epub 2011 Nov 10.

PMID:
22102878
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.

Bragstad K, Martel CJ, Thomsen JS, Jensen KL, Nielsen LP, Aasted B, Fomsgaard A.

Influenza Other Respir Viruses. 2011 Jan;5(1):13-23. doi: 10.1111/j.1750-2659.2010.00177.x. Epub 2010 Nov 3.

PMID:
21138536
[PubMed - indexed for MEDLINE]
11.

Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination.

Choi YS, Baek YH, Kang W, Nam SJ, Lee J, You S, Chang DY, Youn JC, Choi YK, Shin EC.

Clin Vaccine Immunol. 2011 Sep;18(9):1519-23. doi: 10.1128/CVI.05053-11. Epub 2011 Aug 3.

PMID:
21813667
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.

Vaccine. 2012 Jun 22;30(30):4543-51. doi: 10.1016/j.vaccine.2012.03.061. Epub 2012 Apr 1.

PMID:
22475864
[PubMed - indexed for MEDLINE]
13.

Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.

Sun Y, Bian C, Xu K, Hu W, Wang T, Cui J, Wu H, Ling Z, Ji Y, Lin G, Tian L, Zhou Y, Li B, Hu G, Yu N, An W, Pan R, Zhou P, Leng Q, Huang Z, Ma X, Sun B.

PLoS One. 2010 Dec 9;5(12):e14270. doi: 10.1371/journal.pone.0014270.

PMID:
21151563
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[A survey of levels of antibodies against influenza viruses in the population of Wuxi City].

You FX, Sun N, Ma GY, Wang MM, Sa D, Shi C, Wu JL, Lin X, Xiao Y, Qian YH, Jiang Y, Xie J, Ji YY, Guan HX.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):351-4. Chinese.

PMID:
22338222
[PubMed - indexed for MEDLINE]
15.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

PMID:
16950949
[PubMed - indexed for MEDLINE]
Free Article
16.

The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.

Lin SY, Wu ET, Lin CH, Shyu MK, Lee CN.

PLoS One. 2013 Jun 6;8(6):e62983. doi: 10.1371/journal.pone.0062983. Print 2013.

PMID:
23762229
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Safety and immunogenicity on the formulation of trivalent split influenza vaccine among healthy people aged over 18 years].

Wang P, Zhang XW, Song YF, Yin HB, Liu LJ, Che L, Li H, Liu Y, Chen JT.

Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Feb;32(2):120-4. Chinese.

PMID:
21518617
[PubMed - indexed for MEDLINE]
18.

Kinetics of the antibody response to seasonal influenza vaccination among the elderly.

Kositanont U, Assantachai P, Wasi C, Puthavathana P, Praditsuwan R.

Viral Immunol. 2012 Dec;25(6):471-6. doi: 10.1089/vim.2012.0024. Epub 2012 Oct 12.

PMID:
23061793
[PubMed - indexed for MEDLINE]
19.

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.

Loebermann M, Anders G, Brestrich G, Fritzsche C, Klammt S, Boršo D, Frimmel S, Riebold D, Reisinger EC.

Vaccine. 2011 Feb 1;29(6):1228-34. doi: 10.1016/j.vaccine.2010.11.092. Epub 2010 Dec 15.

PMID:
21167116
[PubMed - indexed for MEDLINE]
20.

Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.

Yang P, Zhang L, Shi W, Lu G, Cui S, Peng X, Zhang D, Liu Y, Liang H, Pang X, Wang Q.

Influenza Other Respir Viruses. 2012 Nov;6(6):381-8. doi: 10.1111/j.1750-2659.2011.00326.x. Epub 2011 Dec 30.

PMID:
22212858
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk